In this study, a new multiplex RT-PCR method for detecting various viral genes in patients with rash and fever illnesses (RFIs) was constructed. New primer sets were designed for detection of herpes simplex viruses 1 and 2 (HSV1 and 2), and Epstein-Barr virus (EBV). The newly designed and previously reported primer sets were used to detect 13 types of RFI-associated viruses by multiplex RT-PCR assay systems. Moreover, to eliminate non-specific PCR products, a double-stranded specific DNase was used to digest double-stranded DNA derived from the templates in clinical specimens. RFI-associated viruses were detected in 77.0% of the patients (97/126 cases) by the presented method, multiple viruses being identified in 27.8% of the described cases (35/126 cases). Detected viruses and clinical diagnoses were compatible in 32.5% of the patients (41/126 cases). Sensitivity limits for these viruses were estimated to be 10 1 -10 3 copies/assay. Furthermore, non-specific PCR products were eliminated by a double-stranded specific DNase with no influence on sensitivity. These results suggest that this method can detect various RFIassociated viruses in clinical specimens with high sensitivity and specificity.
confirmation of causative viruses takes several weeks. Moreover, the isolation rates may be low and cell culture methods are not applicable to some viruses, such as B19V. Alternatively, immunofluorescent methods are highly sensitive and specific, but may involve complicated procedures. In contrast, genetic assays such as PCR enable detection of various viruses with high sensitivity and specificity. Indeed, PCR is used for to detect many pathogenic viruses (11) . However, to the best of our knowledge, a highly sensitive PCR method for rapidly detecting many RFI-associated viruses has not yet been developed. Here, a novel multiplex RT-PCR method for detecting 13 types of RFI-associated viruses was constructed.
MATERIALS AND METHODS

Patients and specimens
Summarized data on the patients and specimens are shown in Table 1 . Specimens were collected from patients who were clinically diagnosed as having RFI. Their average age was 14.4 AE 18.3 (mean AE SD). The 232 collected specimens comprised 118 nasopharyngeal swabs, 75 blood and 39 urines samples. The blood specimens included serum, plasma and PBMCs. The PBMCs were isolated using the Ficoll-Hypaque method, as previously described (12) . This study received ethical approval from the Research and Ethics Committee for the Use of Human Subjects of the National Institute of Infectious Diseases, Tokyo, Japan, and was performed according to the approved protocol (No. 435).
Selection of RFI-associated viruses and the primer sets for multiple RT-PCR
Thirteen representative RFI-associated viruses were selected as previously described: HSVs, including HSV1 and HSV2, VZV, EBV, CMV, HHV6, HHV7, MeV, RuV, EV, B19V, HPeV, DENV and CHIKV (13) (14) (15) (16) (17) (18) (19) . Next, to construct the multiplex RT-PCR assay system, primer sets were carefully selected to detect these viruses as previously described (20) (21) (22) (23) (24) (25) . Our preliminary experiments showed that previously reported primers for detection of HSVs and EBV produce non-specific amplicons by the present multiplex RT-PCR using the templates derived from clinical specimens (data not shown). To avoid this, two new primer sets for detecting these viruses were designed using the Primaclade server (26) . The four sets of multiplex RT-PCR were rearranged to include all 13 viruses. Primers sequences and the targeted viruses are shown in Table 2 .
RNA and DNA extraction, elimination of double-stranded DNA and RT-PCR Viral RNA and DNA were extracted from 200 mL of each specimen using a QIAamp MinElute Virus Spin kit (Qiagen, Hilden, Germany) according to the manufacturer's protocol.
Next, preliminary examinations suggested detection of non-specific amplicons by multiplex RT-PCR using set C and D primers in some clinical samples. These amplicons may result from non-specific reactions by the nucleic templates derived from host cells and/or bacteria. Therefore, they were eliminated by adding a doublestranded specific DNase. The DNase reaction protocol was heating at 65°C for 15 min with 1 U of Duplex-specific Nuclease (Evrogen, Moscow, Russia). Degraded templates were purified with a MinElute PCR Purification kit (Qiagen). The RT reaction was performed at 30°C for 10 min, followed by 42°C for 30 min with a total volume of 20 mL including 1 mL of 50 mM random hexamer, 20 U of RNase inhibitor, 200 U of PrimeScript II RTase (Takara, Shiga, Japan) and 12.5 mL of purified template. Reaction mixtures for multiplex PCR contained a total of 50 mL with 10 mL of Q-solution, 1 mL of 10 mM primers, 25 mL of Qiagen Multiplex PCR Master Mix (Qiagen) and 5 mL of template. PCR conditions are shown in Table 2 . 
Sequencing analyses
Sequencing analyses were performed to discriminate between HSV1 and HSV2 in HSV-positive samples from patients with suspected RFIs. Whether the multiplex RT-PCR products were derived from target genes of the RFIassociated viruses was assessed by sequencing analyses using 23 clinical specimens, including two samples for HSVs, two for VZV, one for EBV, two for CMV, two for HHV6, two for HHV7, two for RuV, two for MeV, two for EV, two for B19V, two for HPeV, one for DENV and one for CHIKV. Cycle sequencing was performed at 96°C for one min, followed by a total of 30 cycles of 10 s at 96°C, 10 s at 50°C and 2 min at 60°C using a Big Dye Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems, Carlsbad, CA, USA) in accordance with the manufacturer's instructions. The DNA sequences were analyzed with an Applied Biosystems 3500 Genetic Analyzer (Applied Biosystems). Finally, these sequences were confirmed by BLAST analyses (27) .
Sensitivity limits of each targeted virus in the multiplex PCR
Nucleic templates extracted from positive samples of the targeted viruses were amplified with 1 mL of 10 mM primers and 1.25 U of Takara Ex Taq (Takara). The PCR products that were detected using a 1.5% agarose gel were purified by using a MonoFas DNA Purification kit (GL Sciences, Tokyo, Japan) and a MinElute PCR Purification kit (Qiagen). The purified DNA was quantified with BioSpec Nano (Shimadzu, Kyoto, Japan). Serially diluted amplicons (10 0 to 10 4 copies/mL) were subjected to the multiplex PCR assay to determine the sensitivity limits for each virus. 
RESULTS
Detection of RFI-associated viruses by a multiplex RT-PCR method
A novel multiplex RT-PCR method for detection of 13 types of RFI-associated viruses in clinical specimens was constructed. Preliminary investigation revealed non-specific amplicons in the set C assay using B19V samples (Fig. 1a) . Because these non-specific amplicons were likely to have been derived from other doublestranded DNA templates from human and bacterial genomes in the clinical specimens, the set C and D assays that targeted a single-stranded DNA virus and RNA viruses were first treated with a double-stranded specific DNase to digest double-stranded DNA templates in the DNA and RNA extracted from the samples. After this treatment, non-specific amplicons were not detected, whereas B19V amplicons (singlestranded DNA) were detected; the DNase treatment did not result in any decrease in sensitivity (Fig. 1a) . In addition, no non-specific amplicons were detected by multiplex RT-PCR assays of sets A to D, which included the DNase procedure (Fig. 1b-e) . Moreover, nucleotide sequence analyses of the amplicons for the RFI-associated viruses were performed using BLAST, resulting in all sequences being estimated as the target genes of the viruses (data not shown).
Sensitivity of the multiplex RT-PCR method
The sensitivity of the present method was examined using serially diluted amplicons of each virus. As shown in Table 3 , the sensitivity limits of each virus were confirmed as 10 1 -10 3 copies/assay, suggesting that the new method is highly sensitive in detecting the selected 13 types of RFI-associated viruses (Table 3) .
Detection of RFI-associated viruses in clinical specimens
To detect RFI-associated viruses in patients with RFIs, any viruses present in their specimens were investigated using the described multiplex RT-PCR method. As shown in Table 4 , RFI-associated viruses were detected in 77.0% (97 of 126) of patients with RFIs. The majority of detected viruses were EV (38 cases), HHV6 (32 cases) and HHV7 (26 cases). EBV (12 cases) and CMV (12 cases) were also detected (Table 4) . Additionally, as shown in Table 5 , multiple viruses were detected in 27.8% (35 of 126) of the samples studied ( Table 5 ).
Compatibility of clinical diagnoses and detected viruses
As shown in Table 4 , there were some discrepancies between clinical diagnoses and detected viruses. Overall, there was relatively poor compatibility between clinical diagnoses and detected viruses in the studied cases (32.5%); however, the detected viruses may not have been the direct cause of the RFI in some cases (Table 4) .
DISCUSSION
In this study, a method that enabled detection of 13 types of RFI-associated viruses with high sensitivity (10 1 -10 3 copies/assay) using a multiplex RT-PCR assay was developed. A double-stranded specific DNase succeeded in eliminating non-specific amplicons derived from the templates in the clinical samples with no change in sensitivity. The present multiplex RT-PCR method was able to amplify target genes of the RFI-associated viruses. Moreover, RFI-associated viruses were detected in about 80% of samples from patients with RFI, suggesting that this method may be a highly specific and sensitive means of detecting various RFI-associated viruses. A number of multiplex PCR methods for detecting various viruses have been developed (28) (29) (30) . For example, McIver et al. have developed a multiplex nested RT-PCR method for detecting 14 types of infective organisms (HSV1, HSV2, VZV, EBV, CMV, HHV6, HHV7, HHV8, EV, hepatitis C virus, lymphocytic choriomeningitis virus, B19V, RuV and Toxoplasma gondii) with high sensitivity (2-200 copies/assay). This method aimed to investigate congenital infections in infants (31) . Another method for detecting RFI-associated viruses using real-time RT-PCR has also been developed. However, this method only detects five major RFI-associated viruses (HHV6, HHV7, MeV, RuV and B19V) (32) . Thus, to the best of our knowledge, there is no reported method for detecting the 13 types of RFI-associated viruses studied here. Our unique protocol incorporates double-stranded specific DNase treatment to eliminate non-specific amplicons. Moreover, the method allows us to detect RFI-associated viruses within the required times of approximately 7-9 hr as follows: 1 hr for extraction of RNA and DNA, 1 hr for double-stranded specific DNase treatment and purification, 3-4 hr for multiplex RT-PCR and 2-3 hr for sequencing. In addition, the present method has high sensitivity and specificity for detecting the selected 13 RFIassociated viruses.
Because some of the RFIs, namely measles, rubella and varicella are highly contagious, it is important to rapidly and accurately diagnose RFIs to prevent outbreaks in hospitals and nursery schools (3) (4) (5) . However, RFIs generally have no specific symptoms, an exception being Koplik spots in measles (33, 34) . In the present cases, the compatibility between the clinical diagnosis and the detected viruses was poor (approximately 33%), suggesting that accurate diagnosis of RFIs requires laboratory examination in parallel with clinical procedures. However, we did not investigate whether or not the multiple detected viruses were associated with the clinical diagnoses. Clinicians may take care in drawing conclusions about causative pathogens in patients with RFIs.
